Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 5:13 pm Purchase | 2026-01-27 | 13G | UNIVERSAL SAFETY PRODS INC UUU | Lazar David E. | 281,400 9.900% | 125,004 (+79.93%) | Filing History |
| 2026-04-28 5:29 pm Purchase | 2026-04-22 | 13D | QUANTUM CYBER N.V. QUCY | Lazar David E. | 477,000,000 97.400% | 477,000,000 (New Position) | Filing History |
| 2026-03-24 4:05 pm Sale | 2026-03-23 | 13D | INDAPTUS THERAPEUTICS INC INDP | Lazar David E. | 2,064,000 47.930% | -108,936,000 (-98.14%) | Filing History |
| 2026-03-02 5:20 pm Purchase | 2026-02-26 | 13D | INDAPTUS THERAPEUTICS INC INDP | Lazar David E. | 111,000,000 98.000% | 111,000,000 (New Position) | Filing History |
| 2026-02-06 4:14 pm Purchase | 2026-01-30 | 13D | KALA BIO, INC. KALA | Lazar David E. | 990,000 5.180% | 990,000 (New Position) | Filing History |
| 2026-01-29 7:38 pm Purchase | 2025-10-21 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Lazar David E. | 1,277,600 4.990% | 977,184 (+325.28%) | Filing History |
| 2026-01-26 6:18 pm Purchase | 2026-01-16 | 13G | UNIVERSAL SAFETY PRODS INC UUU | Lazar David E. | 156,396 6.760% | 156,396 (New Position) | Filing History |
| 2025-10-17 5:29 pm Purchase | 2025-10-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Lazar David E. | 300,416 19.990% | 60,406 (+25.17%) | Filing History |
| 2025-08-26 4:11 pm Purchase | 2025-08-19 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Lazar David E. | 240,010 19.990% | 240,010 (New Position) | Filing History |
| 2025-08-19 12:03 pm Purchase | 2025-08-15 | 13G | MATINAS BIOPHARMA HLDGS INC CO MTNB | Lazar David E. | 545,000 9.810% | 545,000 (New Position) | Filing History |
| 2025-08-08 10:52 am Sale | 2025-08-05 | 13D | CYCLACEL PHARMACEUTICALS INC C CYCC | Lazar David E. | 0 0.000% | -129,629 (Position Closed) | Filing History |
| 2025-08-04 7:24 pm Sale | 2025-07-30 | 13D | CYCLACEL PHARMACEUTICALS INC C CYCC | Lazar David E. | 129,629 8.180% | -32,959 (-20.27%) | Filing History |
| 2025-03-10 5:28 pm Sale | 2025-02-18 | 13D | MINIM INC MINM | Lazar David E. | 2,802,254 35.100% | -4,707,226 (-62.68%) | Filing History |
| 2025-02-28 4:46 pm Purchase | 2025-02-06 | 13D | CYCLACEL PHARMACEUTICALS INC C CYCC | Lazar David E. | 162,588 15.840% | 162,588 (New Position) | Filing History |
| 2024-12-31 4:57 pm Purchase | 2024-12-26 | 13D | MINIM INC MINM | Lazar David E. | 7,509,480 78.300% | 9,113 (+0.12%) | Filing History |
| 2024-11-25 4:41 pm Sale | 2024-11-21 | 13D | LQR HSE INC YHC | Lazar David E. | 0 0.000% | -31,481 (Position Closed) | Filing History |
| 2024-11-15 5:00 pm Purchase | 2024-10-21 | 13D | MINIM INC MINM | Lazar David E. | 7,500,367 84.900% | 427,500 (+6.04%) | Filing History |
| 2024-10-21 9:02 pm Purchase | 2024-10-15 | 13D | LQR HSE INC YHC | Lazar David E. | 31,481 19.740% | 31,481 (New Position) | Filing History |
| 2024-08-01 5:25 pm Sale | 2024-07-30 | 13D | OPGEN INC PAR $0.01 OPGN | Lazar David E. | 10,000 13.000% | -239,086 (-95.99%) | Filing History |
| 2024-07-24 5:29 pm Unchanged | 2024-07-22 | 13D | MINIM INC MINM | Lazar David E. | 7,072,867 84.100% | 0 (Unchanged) | Filing History |